Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET biomarkers. This approach aims to deliver earlier, more accurate, and more equitable…